Regulatory
FDA Approves the First Gene Therapy for a Fatal Childhood Brain Disease
Fayuvi, a one-time gene therapy from Ultragenyx, is the first treatment approved for Sanfilippo syndrome type A — a rare disorder that steadily robs children of the abilities they once had.